Digital Health Technologies in Clinical Trials
Digital Health Technologies (DHTs) have revolutionized the landscape of clinical trials, particularly in neurology research, by enabling the collectio…
Digital Health Technologies (DHTs) have revolutionized the landscape of clinical trials, particularly in neurology research, by enabling the collectio…
Through Commure Engage, Yale New Haven Health Automates Personalized Patient Outreach, Boosts Rates of Breast Cancer ScreeningsSAN FRANCISCO--(BUSINESS WIRE)--#commure--Commure Engage (formerly known as Rx.Health), a leading digital health and clinica...
GE HealthCare announced an industry-first US FDA 510K clearance of Critical Care Suite 2.1 featuring a Pneumothorax (PTX) algorithm for the detection, notification, triage and diagnosis of PTX.
The pharmaceutical industry is no stranger to innovation. It has continually evolved, embracing new technologies and methodologies to improve drug dis…
RapidAI, the global leader in developing Artificial Intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, trauma, cardiac and vascular conditions, is proud to announce major milestones in advancing its industry-leading deep clinical AI.
The quest to eliminate lung cancer as a global cause of death has taken a positive step forward with 1 million-milestone met of a 5-million lung health Artificial Intelligence (AI) commitment. This new proactive initiative casts a wider net to currently invisible and unprofiled global patient populations, innovating beyond traditional lung cancer screening profiles such as age and smoking history.
Laudio, an innovator in frontline leader solutions that drive efficiency and engagement for health systems, today announced that Memorial Hermann Health System is implementing Laudio’s platform to enhance employee efficiency and engagement.
In the ever-evolving landscape of pharmaceuticals, innovation has become a guiding force for companies toward a future where healthcare is not only ef…
Oscar Health, Inc., a leading healthcare technology company, is announcing this year’s recipients of its Culturally Competent Care (CCC) Grants. The initiative, which is a component of Oscar’s CCC Program, delivers financial and on-the-ground support to select organizations who provide access to care in underserved communities.
Evinova will operate as a separate health-tech business within AstraZeneca Evinova’s globally-scaled digital health solutions are evidence-led, science-based and human experience-driven to serve clinical trial sponsors, clinical research organisations...